ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

QURE uniQure NV

4.72
0.03 (0.64%)
07 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
uniQure NV NASDAQ:QURE NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.03 0.64% 4.72 4.51 4.72 4.7761 4.61 4.72 328,506 01:00:00

Report of Foreign Issuer (6-k)

16/09/2016 12:23pm

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

 

September 16, 2016

 

uniQure N.V.

 

Matthew Kapusta, Chief Financial Officer
Meibergdreef 61
Amsterdam 1105 BA, the Netherlands; Tel: +31 20 566 7394

(Address, Including ZIP Code, and Telephone Number,

Including Area Code, of Registrant’s Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F   x       Form 40-F    o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):   o

 

 

 



 

Furnished as Exhibit 99.1 to this Report on Form 6-K is a press release of uniQure N.V. (the “ Company ”), dated September 16, 2016, announcing the receipt by the Company of a letter from NASDAQ notifying the Company that the membership of the Company’s Board of Directors did not satisfy NASDAQ’s independence requirements and providing a cure period to correct such deficiency.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

UNIQURE N.V.

 

 

 

 

 

 

Date: September 16, 2016

By:

/s/ Matthew Kapusta

 

Matthew Kapusta

 

Chief Financial Officer

 

3



 

INDEX TO EXHIBITS

 

Number

 

Description

 

 

 

99.1

 

Press release of uniQure N.V., dated September 16, 2016, announcing the receipt by the Company of a letter from NASDAQ notifying the Company that the membership of the Company’s Board of Directors did not satisfy NASDAQ’s independence requirements and providing a cure period to correct such deficiency.

 

4


1 Year uniQure NV Chart

1 Year uniQure NV Chart

1 Month uniQure NV Chart

1 Month uniQure NV Chart

Your Recent History

Delayed Upgrade Clock